Viewing Study NCT00002295



Ignite Creation Date: 2024-05-05 @ 10:22 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002295
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Study of Isoprinosine in Patients With Severe AIDS
Sponsor: Newport Pharmaceuticals International
Organization: NIH AIDS Clinical Trials Information Service

Study Overview

Official Title: A Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine Inosiplex in Patients With Severe Acquired Immunodeficiency Syndrome
Status: COMPLETED
Status Verified Date: 1989-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the effect of Isoprinosine in patients diagnosed as having AIDS relative to

Laboratory immunologic defects

Comparison of total helper and suppressor T-cell numbers among the groups
Comparison of changes in natural killer cell activity
Comparison of other laboratory findings among the groups

Clinical changes

Comparison of the frequency of opportunistic infections among the groups
Comparison of the frequency of the development of AIDS-related malignancies
Comparison of other clinical manifestations relative to severity and time of onset
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
ISO-141-USA None None None